Cite

HARVARD Citation

    von Mentzer, B. et al. (2020). A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine. Journal of pharmacy and pharmacology. pp. 1352-1360. [Online]. 
  
Back to record